tiprankstipranks
Trending News
More News >
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
US Market

Intra-Cellular Therapies (ITCI) Income Statement

Compare
918 Followers

Intra-Cellular Therapies Income Statement

Last quarter (Q4 2024), Intra-Cellular Therapies's total revenue was $199.22M, an increase of 51.49% from the same quarter last year. In Q4, Intra-Cellular Therapies's net income was $-16.89M. See Intra-Cellular Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 680.85M$ 464.37M$ 249.13M$ 81.71M$ 22.53M
Gross Profit
$ 623.89M$ 430.63M$ 228.69M$ 73.67M$ 20.64M
Operating Expenses
$ 740.61M$ 590.01M$ 492.31M$ 359.36M$ 251.86M
Depreciation and Amortization
$ 0.00$ 528.00K$ 656.00K$ 533.36K$ 528.12K
EBITDA
$ -116.72M$ -158.85M$ -262.97M$ -285.15M$ -230.70M
Operating Income
$ -116.72M$ -159.38M$ -263.63M$ -285.69M$ -231.23M
Other Income/Expenses
$ 42.52M$ 20.34M$ 7.38M$ 1.57M$ 4.24M
Pretax Income
$ -74.20M$ -139.04M$ -256.25M$ -284.12M$ -226.99M
Net Income
$ -74.68M$ -139.67M$ -256.26M$ -284.13M$ -227.01M
Per Share Metrics
Basic EPS
$ -0.72$ -1.46$ -2.72$ -3.50$ -3.23
Diluted EPS
$ -0.72$ -1.46$ -2.72$ -3.50$ -3.23
Weighted Average Shares Outstanding
103.13M 95.88M 94.05M 81.25M 70.36M
Weighted Average Shares Outstanding (Diluted)
103.13M 95.88M 94.05M 81.25M 70.36M
Currency in USD

Intra-Cellular Therapies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis